.
SYNGENE financial statements
* Numbers in millions
Year |
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM |
---|---|---|---|---|---|---|---|
Capitalization * |
75 468 | 100 932 | 123 588 | 121 360 | 127 909 | 220 240 | 230 203 |
EV * |
80 505 | 106 914 | 128 935 | 127 841 | 133 716 | 225 949 | 225 949 |
Stock price ¤ |
194.425 | 258.35 | 312 | 306.85 | 322.1 | 553.75 | 578.8 |
Number of shares * |
388 | 391 | 396 | 396 | 397 | 398 | 398 |
EPS |
5,70 | 7,35 | 7,71 | 8,38 | 10,38 | 10,18 | 10,18 |
Revenue * |
10 856 | 11 695 | 13 245 | 17 156 | 18 797 | 20 891 | 20 891 |
Net income * |
2 212 | 2 873 | 3 054 | 3 316 | 4 121 | 4 049 | 4 049 |
Operating profit * |
3 003 | 2 710 | 2 689 | 3 755 | 3 843 | 3 877 | 3 877 |
Total liabilities * |
13 367 | 13 607 | 14 686 | 17 351 | 19 871 | 20 618 | 20 618 |
Net debt * |
5 037 | 5 982 | 5 347 | 6 481 | 5 807 | 5 709 | 5 709 |
Total assets * |
23 895 | 27 738 | 31 890 | 37 035 | 41 629 | 48 832 | 48 832 |
Equity * |
10 528 | 14 131 | 17 204 | 19 684 | 21 758 | 28 214 | 28 214 |
Cash and investments * |
9 963 | 10 677 | 11 251 | 4 929 | 2 978 | 7 897 | 7 897 |
Over the past 10 years, the maximum capitalization of Syngene International Limited is 220 240, the minimum is 75 468. Maximum net income 4 121, Minimum net income 2 212. The maximum price of SYNGENE shares is 553.75, the minimum price is 194.425.
.
SYNGENE valuation
Year |
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM |
---|---|---|---|---|---|---|---|
P/E |
34,12 | 35,13 | 40,47 | 36,60 | 31,04 | 54,39 | 56,85 |
P/B |
7,17 | 7,14 | 7,18 | 6,17 | 5,88 | 7,81 | 8,16 |
P/S |
6,95 | 8,63 | 9,33 | 7,07 | 6,80 | 10,54 | 11,02 |
E/P |
3% | 3% | 2% | 3% | 3% | 2% | 2% |
P/FCF |
369,94 | 110,55 | 149,80 | 257,66 | 376,20 | 86,47 | 90,38 |
.
SYNGENE profitability
Year |
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM |
---|---|---|---|---|---|---|---|
ROE |
21% | 20% | 18% | 17% | 19% | 14% | |
ROA |
9% | 10% | 10% | 9% | 10% | 8% | |
ROIC |
16% | 12% | 11% | 15% | 15% | 10% |